Global Hemp Group Inc.
Global Hemp Group Inc.
Your view on GBHPF
Overview
What the company does, where it operates, and who runs it.
About Global Hemp Group Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Curtis Ralph William Huber
- Headquarters
- 1169 Mount Seymour Road, North Vancouver, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Curtis Ralph William Huber
- Headquarters
- 1169 Mount Seymour Road, North Vancouver, BC, CA
Global Hemp Group Inc. engages in the production and processing of industrial hemp in the United States. It focuses on the development of sustainable and green value-added industrial hemp products utilizing the processing of the hemp plant for multi-merchantable applications.
The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Global Hemp Group Inc., and the rating behind it. GBHPF last traded at $0.0051; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Global Hemp Group Inc.. Starting points for Global Hemp Group Inc.: EPS -$0.15, beta 1.18 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Global Hemp Group Inc.. Global Hemp Group Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Global Hemp Group Inc.. Trailing twelve-month EPS for Global Hemp Group Inc. stands at -$0.15. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Global Hemp Group Inc.. Global Hemp Group Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Global Hemp Group Inc. valued side by side against its closest peers. Global Hemp Group Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Global Hemp Group Inc., and how their positions are changing. At a $123,886 market value, institutional positions materially move Global Hemp Group Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Global Hemp Group Inc. executives and directors. Shares of Global Hemp Group Inc. have traded between $0.0043 and $0.58 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Global Hemp Group Inc.. Global Hemp Group Inc. is a $123,886 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Global Hemp Group Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Global Hemp Group Inc.. Coverage tracks Global Hemp Group Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.